Bioventus (BVS) News Today $11.24 +0.11 (+0.99%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Los Angeles Capital Management LLC Acquires Shares of 143,464 Bioventus Inc. (NYSE:BVS)Los Angeles Capital Management LLC bought a new position in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 143,464 shares of the company's stock, vaNovember 14 at 3:51 AM | marketbeat.comBioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comBioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...November 6, 2024 | finance.yahoo.comQ3 2024 Bioventus Inc Earnings CallNovember 6, 2024 | uk.finance.yahoo.comBioventus (NYSE:BVS) Shares Gap Down - Here's What HappenedBioventus (NYSE:BVS) Shares Gap Down - Time to Sell?November 5, 2024 | marketbeat.comBioventus Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comBioventus (NYSE:BVS) Updates FY24 Earnings GuidanceBioventus (NYSE:BVS) updated its FY24 earnings guidance. The company provided EPS guidance of $0.40-0.42 for the period, compared to the consensus estimate of $0.39. The company also issued revenue guidance of $562-567 millionillion, compared to the consensus estimate of $561.76 millionillion.November 5, 2024 | marketbeat.comBioventus Reports Third Quarter Financial ResultsNovember 5, 2024 | globenewswire.comBioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look ForNovember 4, 2024 | finance.yahoo.comBioventus (BVS) Set to Announce Quarterly Earnings on TuesdayBioventus (NYSE:BVS) will be releasing earnings before the market opens on Tuesday, November 5, Zacks reports.October 30, 2024 | marketbeat.comBioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024October 29, 2024 | globenewswire.comBioventus files to sell 35.04M shares of Class A common stock for holdersOctober 26, 2024 | markets.businessinsider.comBioventus files $200M mixed securities shelfOctober 26, 2024 | markets.businessinsider.comBioventus (NYSE:BVS) Sets New 1-Year High - Time to Buy?Bioventus (NYSE:BVS) Hits New 12-Month High - What's Next?October 23, 2024 | marketbeat.comBioventus (NASDAQ:BVS) Stock Quotes, Forecast and News SummaryOctober 19, 2024 | benzinga.comBioventus (NYSE:BVS) Reaches New 52-Week High - Still a Buy?Bioventus (NYSE:BVS) Hits New 52-Week High - Time to Buy?October 14, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP increased its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 100.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 117,496 shares of the company's stockOctober 14, 2024 | marketbeat.comBioventus (NYSE:BVS) Trading Up 7.5% - Here's What HappenedBioventus (NYSE:BVS) Shares Up 7.5% - Time to Buy?October 11, 2024 | marketbeat.comBioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 10, 2024 | finance.yahoo.comDurham public company inks $45M deal to divest business unitOctober 8, 2024 | bizjournals.com133,641 Shares in Bioventus Inc. (NYSE:BVS) Acquired by Bank of Montreal CanBank of Montreal Can acquired a new stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 133,641 shares of the company's stock, valued at apOctober 8, 2024 | marketbeat.comMarshall Wace LLP Has $1.91 Million Stock Holdings in Bioventus Inc. (NYSE:BVS)Marshall Wace LLP grew its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 38.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 332,291 shares of the company's stock after purchasing an additional 91,843 shOctober 5, 2024 | marketbeat.comBioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed PartnersOctober 1, 2024 | finance.yahoo.comBioventus Inc. (NYSE:BVS) Shares Sold by Nantahala Capital Management LLCNantahala Capital Management LLC reduced its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 8.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,338,314 shares of the company's stock afterOctober 1, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Bought by Rhumbline AdvisersRhumbline Advisers grew its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 5,367.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,437 shares of the company's stock after acquiringSeptember 28, 2024 | marketbeat.comBioventus (NYSE:BVS) Sets New 12-Month High After Analyst UpgradeBioventus (NYSE:BVS) Hits New 52-Week High After Analyst UpgradeSeptember 27, 2024 | marketbeat.comBank of New York Mellon Corp Takes Position in Bioventus Inc. (NYSE:BVS)Bank of New York Mellon Corp bought a new stake in Bioventus Inc. (NYSE:BVS - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 112,477 shares of the company's stock, valued at approximately $647,000. Bank of New York MelloSeptember 24, 2024 | marketbeat.comMarathon Trading Investment Management LLC Sells 45,259 Shares of Bioventus Inc. (NYSE:BVS)Marathon Trading Investment Management LLC decreased its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 70.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,841 shares of the compSeptember 19, 2024 | marketbeat.comBioventus (NYSE:BVS) Reaches New 12-Month High at $11.52Bioventus (NYSE:BVS) Reaches New 12-Month High at $11.52September 16, 2024 | marketbeat.comBioventus (NYSE:BVS) Shares Gap Up to $10.53Bioventus (NYSE:BVS) Shares Gap Up to $10.53September 12, 2024 | marketbeat.comBioventus (NYSE:BVS) Sets New 52-Week High at $10.53Bioventus (NYSE:BVS) Sets New 1-Year High at $10.53September 10, 2024 | marketbeat.comBioventus (NYSE:BVS) Stock Price Up 6.2%Bioventus (NYSE:BVS) Trading Up 6.2%September 9, 2024 | marketbeat.comPanagora Asset Management Inc. Makes New Investment in Bioventus Inc. (NYSE:BVS)Panagora Asset Management Inc. acquired a new stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 136,849 shares of the company's stock, valued at approximatelySeptember 3, 2024 | marketbeat.comBioventus and Pool have been highlighted as Zacks Bull and Bear of the DayAugust 29, 2024 | finance.yahoo.comBioventus (NYSE:BVS) Trading 4.5% Higher Bioventus (NYSE:BVS) Trading Up 4.5%August 22, 2024 | marketbeat.comBioventus (NYSE:BVS) Reaches New 12-Month High Following Insider Buying ActivityBioventus (NYSE:BVS) Hits New 12-Month High on Insider Buying ActivityAugust 21, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) Director John A. Bartholdson Acquires 25,500 SharesAugust 21, 2024 | insidertrades.comBioventus Inc. (NYSE:BVS) Director John A. Bartholdson Acquires 80,000 SharesAugust 21, 2024 | insidertrades.comInsider Buying: Bioventus Inc. (NYSE:BVS) Director Purchases 25,500 Shares of StockBioventus Inc. (NYSE:BVS - Get Free Report) Director John A. Bartholdson purchased 25,500 shares of the company's stock in a transaction that occurred on Monday, August 19th. The stock was bought at an average price of $8.55 per share, with a total value of $218,025.00. Following the purchase, the director now owns 6,939,357 shares of the company's stock, valued at approximately $59,331,502.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.August 20, 2024 | marketbeat.comBioventus (NYSE:BVS) Sees Strong Trading VolumeBioventus (NYSE:BVS) Sees Large Volume IncreaseAugust 19, 2024 | marketbeat.comBioventus (NYSE:BVS) Sets New 52-Week High at $8.37Bioventus (NYSE:BVS) Hits New 12-Month High at $8.37August 15, 2024 | marketbeat.comBioventus (NYSE:BVS) Trading Down 4.2%Bioventus (NYSE:BVS) Shares Down 4.2%August 14, 2024 | marketbeat.comBioventus (NYSE:BVS) Sees Unusually-High Trading Volume After Analyst UpgradeBioventus (NYSE:BVS) Sees Unusually-High Trading Volume After Analyst UpgradeAugust 13, 2024 | marketbeat.comBioventus (NYSE:BVS) Price Target Raised to $12.00Canaccord Genuity Group boosted their price target on Bioventus from $8.00 to $12.00 and gave the company a "buy" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comBioventus Inc. (BVS) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comHealing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024August 12, 2024 | seekingalpha.comBioventus (NYSE:BVS) Issues Earnings Results, Beats Expectations By $0.12 EPSBioventus (NYSE:BVS - Get Free Report) released its earnings results on Tuesday. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.12. The company had revenue of $151.22 million during the quarter, compared to the consensus estimate of $137.70 million. Bioventus had a positive return on equity of 11.91% and a negative net margin of 4.14%. During the same quarter in the previous year, the company posted $0.14 earnings per share.August 7, 2024 | marketbeat.comBioventus to Present at the Canaccord Genuity 44th Annual Global Growth ConferenceAugust 7, 2024 | globenewswire.comBioventus (NYSE:BVS) Sets New 52-Week High After Strong EarningsBioventus (NYSE:BVS) Hits New 1-Year High on Better-Than-Expected EarningsAugust 7, 2024 | marketbeat.comBioventus (NYSE:BVS) Issues FY 2024 Earnings GuidanceBioventus (NYSE:BVS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.360-0.420 for the period, compared to the consensus estimate of 0.280. The company also issued revenue guidance of $557.0 millionillion-$567.0 millionillion, compared to the consensus estimate of $542.8 millionillion.August 7, 2024 | marketbeat.com Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… BVS Media Mentions By Week BVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVS News Sentiment▼1.760.56▲Average Medical News Sentiment BVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVS Articles This Week▼12▲BVS Articles Average Week Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Envista News Axonics News Inari Medical News TransMedics Group News LivaNova News iRhythm Technologies News Enovis News CONMED News Soleno Therapeutics News Tandem Diabetes Care News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BVS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
